|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
389,580,000 |
Market
Cap: |
45.11(B) |
Last
Volume: |
3,009,533 |
Avg
Vol: |
1,927,028 |
52
Week Range: |
$75.49 - $140.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 487 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
214,192 |
275,430 |
303,186 |
572,710 |
Total Sell Value |
$28,873,866 |
$36,403,178 |
$39,551,376 |
$69,690,287 |
Total People Sold |
7 |
9 |
14 |
15 |
Total Sell Transactions |
15 |
25 |
46 |
79 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-09-25 |
4 |
AS |
$400.07 |
$800,137 |
D/D |
(2,000) |
65,218 |
|
0% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-09-24 |
4 |
AS |
$380.31 |
$582,861 |
I/I |
(1,530) |
0 |
|
8% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-09-23 |
4 |
AS |
$395.11 |
$426,324 |
D/D |
(1,079) |
67,218 |
|
4% |
|
Augustinos Nicholas |
Director |
|
2020-09-16 |
4 |
AS |
$396.51 |
$749,596 |
I/I |
(1,875) |
13,842 |
|
-7% |
|
Balo Andrew K |
* |
|
2020-09-15 |
4 |
AS |
$397.35 |
$2,088,490 |
D/D |
(5,256) |
35,567 |
|
-12% |
|
Altman Steven R |
Director |
|
2020-09-15 |
4 |
S |
$393.92 |
$11,817,600 |
I/I |
(30,000) |
12,980 |
|
12% |
|
Foletta Mark G |
Director |
|
2020-09-14 |
4 |
AS |
$386.21 |
$394,136 |
I/I |
(1,000) |
15,202 |
|
-8% |
|
Blackford Quentin S. |
Chief Operating Officer & CFO |
|
2020-09-10 |
4 |
AS |
$397.03 |
$4,884,343 |
D/D |
(12,193) |
44,124 |
|
-5% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-09-10 |
4 |
AS |
$399.60 |
$842,104 |
D/D |
(2,102) |
17,753 |
|
-5% |
|
Sylvain Jereme M |
SVP, Finance & CAO |
|
2020-09-09 |
4 |
S |
$398.30 |
$115,109 |
D/D |
(289) |
12,532 |
|
9% |
|
Abbey Donald |
EVP Quality and Regulatory Aff |
|
2020-09-09 |
4 |
AS |
$391.00 |
$3,841,392 |
D/D |
(9,739) |
50,202 |
|
-9% |
|
Sayer Kevin R |
President, CEO and Chairman |
|
2020-09-09 |
4 |
S |
$398.30 |
$3,969,079 |
D/D |
(9,965) |
142,577 |
|
9% |
|
Moy Jeffrey |
EVP Operations |
|
2020-09-09 |
4 |
D |
$398.30 |
$1,425,921 |
I/I |
(3,580) |
34,784 |
|
- |
|
Moy Jeffrey |
EVP Operations |
|
2020-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
6,967 |
38,364 |
|
- |
|
Moy Jeffrey |
EVP Operations |
|
2020-09-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,967) |
19,684 |
|
- |
|
Blackford Quentin S. |
Chief Operating Officer & CFO |
|
2020-09-09 |
4 |
AS |
$398.30 |
$5,132,520 |
D/D |
(12,886) |
56,317 |
|
-9% |
|
Leach Jacob Steven |
EVP Chief Technology Officer |
|
2020-09-09 |
4 |
S |
$398.30 |
$1,537,446 |
D/D |
(3,860) |
103,548 |
|
9% |
|
Balo Andrew K |
* |
|
2020-09-09 |
4 |
S |
$398.30 |
$1,824,223 |
D/D |
(4,580) |
40,823 |
|
9% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2020-09-09 |
4 |
S |
$398.30 |
$973,450 |
D/D |
(2,444) |
25,732 |
|
9% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-09-09 |
4 |
S |
$398.30 |
$1,871,621 |
D/D |
(4,699) |
46,812 |
|
9% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-09-09 |
4 |
S |
$398.30 |
$1,824,223 |
D/D |
(4,580) |
68,297 |
|
9% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-09-09 |
4 |
AS |
$398.30 |
$886,620 |
D/D |
(2,226) |
19,855 |
|
-9% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-08-24 |
4 |
AS |
$427.24 |
$654,107 |
D/D |
(1,531) |
72,877 |
|
-11% |
|
Abbey Donald |
EVP Quality and Regulatory Aff |
|
2020-08-24 |
4 |
AS |
$421.46 |
$4,147,227 |
D/D |
(9,766) |
59,941 |
|
-11% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-08-24 |
4 |
AS |
$427.22 |
$653,642 |
I/I |
(1,530) |
1,530 |
|
-11% |
|
2303 Records found
|
|
Page 18 of 93 |
|
|